2,017 Shares in McKesson Corporation $MCK Bought by Alamar Capital Management LLC

Alamar Capital Management LLC purchased a new stake in shares of McKesson Corporation (NYSE:MCK) during the first quarter, HoldingsChannel reports. The fund purchased 2,017 shares of the company’s stock, valued at approximately $1,747,000.

Several other institutional investors have also bought and sold shares of MCK. Cetera Investment Advisers grew its stake in shares of McKesson by 15.2% in the 1st quarter. Cetera Investment Advisers now owns 68,415 shares of the company’s stock worth $59,203,000 after buying an additional 9,005 shares in the last quarter. Signature Equity Partners LLC raised its position in shares of McKesson by 25.5% during the 1st quarter. Signature Equity Partners LLC now owns 256 shares of the company’s stock valued at $222,000 after buying an additional 52 shares in the last quarter. First Citizens Bank & Trust Co. lifted its holdings in shares of McKesson by 1.5% in the 1st quarter. First Citizens Bank & Trust Co. now owns 2,061 shares of the company’s stock valued at $1,784,000 after acquiring an additional 30 shares during the last quarter. Alesco Advisors LLC An ESL Co bought a new position in shares of McKesson in the 1st quarter valued at about $203,000. Finally, CI Investments Inc. grew its position in McKesson by 445.2% in the first quarter. CI Investments Inc. now owns 56,345 shares of the company’s stock worth $48,759,000 after acquiring an additional 46,010 shares in the last quarter. Institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

MCK has been the topic of several analyst reports. Citigroup reduced their price objective on McKesson from $975.00 to $945.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. UBS Group raised their price objective on McKesson from $1,000.00 to $1,050.00 and gave the company a “buy” rating in a research note on Friday, May 8th. JPMorgan Chase & Co. dropped their target price on McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating for the company in a report on Friday, May 8th. TD Cowen cut their target price on McKesson from $1,012.00 to $989.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, Wells Fargo & Company decreased their price target on McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 12th. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $959.00.

Trending Headlines about McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson raised its quarterly dividend by about 15% to $0.94 per share, signaling confidence in cash flow and capital returns. The increase was announced alongside a new payment schedule for shareholders of record on September 1. McKesson Corporation Raises Quarterly Dividend by 15% to $0.94 Per Share
• Positive Sentiment: Analysts remain constructive overall: TD Cowen lowered its price target slightly to $989 from $1,012 but kept a buy rating, implying meaningful upside from current levels. TD Cowen price target update via Benzinga
• Neutral Sentiment: Recent Zacks articles note that McKesson is drawing investor attention and is still viewed as a strong growth stock, but these pieces are largely commentary rather than new fundamental catalysts. Why McKesson Fell More Than Broader Market
• Neutral Sentiment: Other recent posts focus on stock performance over time and whether MCK is a buy now, but they do not appear to add a major new operational catalyst. Is Trending Stock McKesson Corporation (MCK) a Buy Now?
• Negative Sentiment: McKesson has been declining more than the broader market in recent sessions, reflecting near-term selling pressure even after strong longer-term fundamentals. Here’s Why McKesson (MCK) Fell More Than Broader Market

Insiders Place Their Bets

In other news, EVP Michele Lau sold 3,550 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the completion of the sale, the executive vice president directly owned 3,247 shares of the company’s stock, valued at approximately $2,471,259.23. The trade was a 52.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Brian S. Tyler sold 8,463 shares of the company’s stock in a transaction dated Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the completion of the transaction, the chief executive officer owned 5,919 shares in the company, valued at approximately $4,697,081.64. The trade was a 58.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 28,748 shares of company stock valued at $22,262,035 in the last three months. 0.06% of the stock is owned by company insiders.

McKesson Stock Performance

MCK opened at $813.95 on Thursday. The stock’s 50 day moving average price is $776.87 and its 200-day moving average price is $838.43. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00. The stock has a market cap of $95.30 billion, a price-to-earnings ratio of 21.16, a P/E/G ratio of 1.36 and a beta of 0.31.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The firm had revenue of $96.30 billion during the quarter, compared to analyst estimates of $101.35 billion. During the same period last year, the company earned $10.12 EPS. McKesson’s quarterly revenue was up 6.0% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. As a group, analysts predict that McKesson Corporation will post 44.28 earnings per share for the current fiscal year.

McKesson Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a dividend yield of 0.5%. This is a positive change from McKesson’s previous quarterly dividend of $0.82. The ex-dividend date is Tuesday, September 1st. McKesson’s dividend payout ratio is 8.53%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.